Oryzon Genomics SA
MAD:ORY

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
MAD:ORY
Watchlist
Price: 3.09 EUR -2.68% Market Closed
Market Cap: 246.9m EUR

Wall Street
Price Targets

ORY Price Targets Summary
Oryzon Genomics SA

Wall Street analysts forecast ORY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORY is 7.5 EUR with a low forecast of 4.04 EUR and a high forecast of 12.6 EUR.

Lowest
Price Target
4.04 EUR
31% Upside
Average
Price Target
7.5 EUR
143% Upside
Highest
Price Target
12.6 EUR
308% Upside
Oryzon Genomics SA Competitors:
Price Targets
VOR
Vor Biopharma Inc
226% Upside
PBYI
Puma Biotechnology Inc
19% Downside
BIOCON
Biocon Ltd
13% Upside
TGTX
TG Therapeutics Inc
44% Upside
MNKD
MannKind Corp
56% Upside
ALKS
Alkermes Plc
57% Upside
TWST
Twist Bioscience Corp
27% Upside
PASG
Passage Bio Inc
312% Upside

Revenue
Forecast

Revenue Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss

Net Income
Forecast

Net Income Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-50%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORY's stock price target?
Price Target
7.5 EUR

According to Wall Street analysts, the average 1-year price target for ORY is 7.5 EUR with a low forecast of 4.04 EUR and a high forecast of 12.6 EUR.

Back to Top